FDA approves 1st new treatment for essential thrombocythemia in nearly three decades
The FDA’s decision was primarily supported by clinical data from the global phase 3 SURPASS-ET clinical trial, which demonstrated that the therapy achieved
Trending now
Myeloproliferative Neoplasms
News
Myeloproliferative Neoplasms
Primary Myelofibrosis
News
FDA receives sNDA for selinexor, ruxolitinib in myelofibrosis
The submission is based on data from the phase 3 SENTRY trial, which evaluated the combination in JAK inhibitor-naive patients and demonstrated spleen
Myelodysplastic Syndromes
News
LYT-200 receives FDA Fast Track Designation for relapsed or refractory high-risk MDS
Feedback from the FDA supports advancing the therapy into STRIDE-MDS, a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating the efficacy, safety, and
News
Society Updates
4th SOHO Israel Meeting registration open, meeting to be held November 19–20, 2026
Registration for the 4th SOHO-Israel Meeting & 10th International Davidoff Conference is open for online and in-person registration. The meeting is scheduled for
SOHO 2026
Video Interviews
Society Updates
Young Investigator Program
Young investigators define the SOHO difference
In this video, recipients of the SOHO Young Investigator Awards share how attending the SOHO Annual Meeting has expanded their clinical knowledge and
MDS News
SOHO 2026
Meeting News
Meetings / Conferences
Video Interviews
Drs. Nastoupil, Garcia-Manero discuss aplastic anemia advances & the future of research funding
Dr. Garcia-Manero introduces Neal Young, MD, of the National Heart, Lung, and Blood Institute (NHLBI) as the chosen plenary speaker, citing his foundational
SOHO 2026
News
Advancing care means protecting the environment that makes discovery possible
These past two years have been plagued with instability, whether perceived or real, as well as a lack of transparency. The current environment
Lymphoma News
SOHO 2026
News
SOHO 2026: Pharma trials in lymphoma with Drs. Nastoupil, Shah
At 8 am on Wednesday, September 9 during the SOHO 2026 Annual Meeting, Nirav Shah, MD, will lead a Meet-the-Professor session on pharma
MDS News
SOHO 2026
Meetings / Conferences
Video Interviews
What can research funding entities do to help progress in MDS with Timothy Graubert, MD
The conversation covers how funding organizations support the international MDS research community by deploying flexible financial resources, offering faculty transition awards to build
Acute Lymphoblastic Leukemia News
Leukemia News
SOHO 2026
Cellular Therapy
Leukemia
Acute Lymphoblastic Leukemia
News
Video Interviews
Dr. DiPersio previews the SOHO 2026 ALL session to be held on Wednesday, September 9
The discussion focuses on whether patients in complete molecular remission still need an allogeneic stem cell transplant, alongside methods to prevent T-cell fratricide